维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="BAFALOUKOS D"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Combination of pegylated liposomal doxorubiein(PLD) and paelitaxel in patients with advanced soft tissue sareoma:a phase Ⅱ study of the Hellenic Cooperative Oncology Group显示文摘	Bafaloukos D Papadimitriou C Linardoul H	2004	British Journal of Cancer2004，91，9：	1
2	Neo-adjuvant therapy in breast cancer显示文摘	BAFALOUKOS D	2005	Ann Oncol2005，162，：	1
3	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh U Bafaloukos D	2009	Nat Rev Clin Oncol2009，6，6：	1
4	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh IJ Bafaloukos D	2009	NatRev Clin Oncol2009，6，6：	1
5	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh I J Bafaloukos D et at	2009	Nat Rev Clin Oncol2009，6，6：	1
6	PhaseⅡstudy of docetaxel-vinorelbine in platinum-resistant,paclitaxel-pretreated ovarian cancer显示文摘	Aravantions G Bafaloukos D Fountzilas G	2003	Ann oncol2003，14，7：	1
7	Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic Cooperative Oncology Group Phase Ⅱ Study 显示文摘	Fountzilas G Nikoaides C Bafaloukos D	2000	Cancer Invest2000，18，6：	1
8	The treatment of brain metastases in melano- ma Patients 显示文摘	Bafaloukos D Gogas H	2004	Cancer Treat Rev2004，30，6：	1
9	Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa- 2b in patients with reseeted high-risk melanoma显示文摘	Peetasides D Dafni U Bafaloukos D	2009	J Clin Oneol2009，27，6：	1
10	Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcima:a phase Ⅱ study of the Hellenic Cooperative Oncology Group 显示文摘	Bafaloukos D Papadimitriou C Linardou H	2004	Br J Cancer2004，91，9：	1
11	Randomized phase III study of I month versus 1 year of adjuvant high-dose interferon alfa- 2b in patients with resected high-risk melanoma 显示文摘	Pectasides D Dafni U Bafaloukos D	2009	J Clin Oncol2009，27，6：	1
12	Metastatic breast cancer with liver metastases : a registry analysis of clinico- pathologic, management and outcome characteristics of 500women 显示文摘	Pentheroudakis G Fountzilas G Bafaloukos D	2006	Breast Cancer Res Treat2006，97，3：	1
13	Paclitaxel,epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group(HeCOG) study显示文摘	Bafaloukos D Bozas G Kalofonos H	2008	Gynecol Oncol2008，110，1：	1
14	Paclitaxel,topotecan,and carboplatin in metastatic endometrial cancinoma:a hellenic co-operative oncology group(HeCOG)study显示文摘	Papadimitriou CA Fountzilas G Bafaloukos D	2008	Gynecologic Oncology2008，111，1：	1
15	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted a- gents:a systematic review and recta-analysis of studies in ad- vanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D Siannis F Bafaloukos D Kosmidis P	2008	Lancet Oncol2008，9，：	1
16	EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC显示文摘	Linardou H Dahabreh l J Bafaloukos D	2009	Nat Rev Clin OncoL2009，6，6：	1
17	A randomized phase Ⅲ trial of 1 month versus 1 year adjuvant high-dose interferon alfa- 2b in patients with resected high risk melanoma显示文摘	Gogas H Dafni U Bafaloukos D	2007	J Clin Oncol2007，25，18：	1
18	Phase Ⅱ study of docetaxel-vinorelbine in platinum-resistant,paclitaxel-pretreated ovarian cancer显示文摘	Aravantinos G Bafaloukos D Fountzilas G	2003	Ann Oncol2003，14，7：	1
19	Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase Ⅱ study 显示文摘	Fountzilas G Nicolaides C Bafaloukos D	2000	Cancer Invest2000，18，6：	1
20	Phase Ⅱstudy of temozolomide in heavily pretreated cancer patients with brain metastases 显示文摘	Christodoulou C Bafaloukos D Kosmidis P	2001	Ann Oncol2001，12，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示